3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Terminated
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Lymphoid
1
Conditions
Lymphoma
14
Lymphoma, Large B-Cell, Diffuse
10
Glioblastoma
8
Astrocytoma
6
Multiple Myeloma
5
Lymphoma, Non-Hodgkin
5
Lymphoma, Follicular
5
Lymphoma, Large-Cell, Immunoblastic
4
Glioma
4
Central Nervous System Neoplasms
4
Neoplasms
3
Hodgkin Disease
3
Gliosarcoma
3
Brain Neoplasms
3
Precursor Cell Lymphoblastic Leukemia-Lymphoma
2
Neoplasms, Plasma Cell
2
Lymphoma, Mantle-Cell
2
Leukemia
2
Breast Neoplasms
2
Oligodendroglioma
1
Neutropenia
1
Neoplasms by Histologic Type
1
Lymphoproliferative Disorders
1
Lymphoma, T-Cell
1
Lymphoma, B-Cell
1
Lymphatic Diseases
1
Leukemia, Myelomonocytic, Acute
1
Leukemia, Myeloid, Acute
1
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
1
Leukemia, Monocytic, Acute
1
Interventions
ponatinib
2
napabucasin
2
Irinotecan
2
Imatinib Mesylate
2
Gemcitabine
2
130-nm albumin-bound paclitaxel
2
pralsetinib
1
pembrolizumab
1
nilotinib
1
linifanib
1
ibritumomab tiuxetan
1
bosutinib
1
Vorinostat
1
Temozolomide
1
Sorafenib
1
Rituximab
1
Pemetrexed
1
Paclitaxel
1
Melphalan
1
Leucovorin
1
Fluorouracil
1
FANG vaccine
1
Etoposide
1
Cytarabine
1
Cisplatin
1
Carmustine
1
Carboplatin
1
Bortezomib
1
Bevacizumab
1
BID protein, human
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 3
×
Neoplasms by Histologic Type
×
Carmustine
×
Clear all
NCT02366663
2018-03-12
SPINOZA
City of Hope Medical Center
Phase 3
Terminated
3 enrolled
8 charts